SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Silzle T)
 

Sökning: WFRF:(Silzle T) > (2020) > Guideline-based ind...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003887naa a2200637 4500
001oai:prod.swepub.kib.ki.se:144530715
003SwePub
008240701s2020 | |||||||||||000 ||eng|
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1445307152 URI
024a https://doi.org/10.1182/bloodadvances.20200023142 DOI
040 a (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Stojkov, K4 aut
2451 0a Guideline-based indicators for adult patients with myelodysplastic syndromes
264 c 2020-08-25
264 1b American Society of Hematology,c 2020
520 a Myelodysplastic syndromes (MDSs) represent a heterogeneous group of hematological stem cell disorders with an increasing burden on health care systems. Evidence-based MDS guidelines and recommendations (G/Rs) are published but do not necessarily translate into better quality of care if adherence is not maintained in daily clinical practice. Guideline-based indicators (GBIs) are measurable elements for the standardized assessment of quality of care and, thus far, have not been developed for adult MDS patients. To this end, we screened relevant G/Rs published between 1999 and 2018 and aggregated all available information as candidate GBIs into a formalized handbook as the basis for the subsequent consensus rating procedure. An international multidisciplinary expert panel group (EPG) of acknowledged MDS experts (n = 17), health professionals (n = 7), and patient advocates (n = 5) was appointed. The EPG feedback rates for the first and second round were 82% (23 of 28) and 96% (26 of 27), respectively. A final set of 29 GBIs for the 3 domains of diagnosis (n = 14), therapy (n = 8), and provider/infrastructural characteristics (n = 7) achieved the predefined agreement score for selection (>70%). We identified shortcomings in standardization of patient-reported outcomes, toxicity, and geriatric assessments that need to be optimized in the future. Our GBIs represent the first comprehensive consensus on measurable elements addressing best practice performance, outcomes, and structural resources. They can be used as a standardized instrument with the goal of assessing, comparing, and fostering good quality of care within clinical development cycles in the daily care of adult MDS patients.
700a Silzle, T4 aut
700a Stussi, G4 aut
700a Schwappach, D4 aut
700a Bernhard, J4 aut
700a Bowen, D4 aut
700a Cermak, J4 aut
700a Dinmohamed, AG4 aut
700a Eeltink, C4 aut
700a Eggmann, S4 aut
700a Fenaux, P4 aut
700a Germing, U4 aut
700a Haschke, M4 aut
700a Hellstrom-Lindberg, Eu Karolinska Institutet4 aut
700a Heger, M4 aut
700a van de Loosdrecht, AA4 aut
700a Passweg, J4 aut
700a Pfeilstocker, M4 aut
700a Platzbecker, U4 aut
700a Malcovati, L4 aut
700a de Almeida, AM4 aut
700a Mittelman, M4 aut
700a Morgenthaler, C4 aut
700a Steensma, DP4 aut
700a Santini, V4 aut
700a Stauder, R4 aut
700a Symeonidis, A4 aut
700a Schaer, S4 aut
700a Maddox, C4 aut
700a de Witte, T4 aut
700a Bohlius, J4 aut
700a Bonadies, N4 aut
710a Karolinska Institutet4 org
773t Blood advancesd : American Society of Hematologyg 4:16, s. 4029-4044q 4:16<4029-4044x 2473-9537x 2473-9529
856u https://ashpublications.org/bloodadvances/article-pdf/4/16/4029/1756394/advancesadv2020002314.pdf
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:144530715
8564 8u https://doi.org/10.1182/bloodadvances.2020002314

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy